Bacterial targeted tumour therapy-dawn of a new era
- 1 January 2008
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 259 (1) , 16-27
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- The ClosTron: A universal gene knock-out system for the genus ClostridiumJournal of Microbiological Methods, 2007
- Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumoursEuropean Journal of Cancer, 2007
- Intravesical instillation therapy with bacillus Calmette‐Guérin for superficial bladder cancer: Study of the mechanism of bacillus Calmette‐Guérin immunotherapyInternational Journal of Urology, 2007
- Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivoBritish Journal of Cancer, 2006
- A Group II Intron-encoded Maturase Functions Preferentially In Cis and Requires Both the Reverse Transcriptase and X Domains to Promote RNA SplicingJournal of Molecular Biology, 2004
- Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patientsCancer Gene Therapy, 2003
- Chemotherapeutic tumour targeting using clostridial sporesFEMS Microbiology Reviews, 1995
- Group II self-splicing introns in bacteriaNature, 1993
- The ClassicClinical Orthopaedics and Related Research, 1991
- Clostridial oncolysis in manEuropean Journal of Cancer (1965), 1967